Forte Biosciences Stock Performance
| FBRX Stock | USD 16.08 0.08 0.50% |
Forte Biosciences holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.65, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Forte Biosciences will likely underperform. Use Forte Biosciences potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to analyze future returns on Forte Biosciences.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.62) | Five Day Return 47.42 | Year To Date Return (25.69) | Ten Year Return (99.67) | All Time Return (99.67) |
Last Split Factor 1:25 | Dividend Date 2020-06-16 | Last Split Date 2024-08-28 |
1 | Disposition of 9375 shares by Riley Antony A of Forte Biosciences subject to Rule 16b-3 | 09/06/2024 |
2 | Insider Trading | 09/17/2024 |
3 | Forte Biosciences reshuffles board, settles lawsuit - Investing.com | 09/20/2024 |
4 | Disposition of 1250 shares by Paul Wagner of Forte Biosciences subject to Rule 16b-3 | 10/01/2024 |
5 | Traders Purchase Large Volume of Forte Biosciences Call Options | 10/17/2024 |
6 | Forte Biosciences Upgraded to Buy What Does It Mean for the Stock | 11/19/2024 |
7 | Forte Biosciences Shares Are Soaring Today Whats Going On | 11/20/2024 |
8 | Acquisition by Riley Antony A of 22514 shares of Forte Biosciences at 5.552 subject to Rule 16b-3 | 11/21/2024 |
| Begin Period Cash Flow | 41.1 M |
Forte |
Forte Biosciences Relative Risk vs. Return Landscape
If you would invest 773.00 in Forte Biosciences on August 28, 2024 and sell it today you would earn a total of 835.00 from holding Forte Biosciences or generate 108.02% return on investment over 90 days. Forte Biosciences is currently generating 1.9777% in daily expected returns and assumes 16.7391% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Forte, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Forte Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Forte Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Forte Biosciences, and traders can use it to determine the average amount a Forte Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1181
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | FBRX | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.74 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.98 actual daily | 39 61% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Forte Biosciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Forte Biosciences by adding it to a well-diversified portfolio.
Forte Biosciences Fundamentals Growth
Forte Stock prices reflect investors' perceptions of the future prospects and financial health of Forte Biosciences, and Forte Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Forte Stock performance.
| Return On Equity | -1.71 | ||||
| Return On Asset | -0.81 | ||||
| Current Valuation | 7.03 M | ||||
| Shares Outstanding | 1.46 M | ||||
| Price To Book | 2.50 X | ||||
| EBITDA | (32.48 M) | ||||
| Net Income | (31.48 M) | ||||
| Cash And Equivalents | 38.55 M | ||||
| Cash Per Share | 1.89 X | ||||
| Total Debt | 3.67 M | ||||
| Current Ratio | 25.67 X | ||||
| Book Value Per Share | 24.30 X | ||||
| Cash Flow From Operations | (28.71 M) | ||||
| Earnings Per Share | (16.38) X | ||||
| Market Capitalization | 23.39 M | ||||
| Total Asset | 38.98 M | ||||
| Retained Earnings | (118.52 M) | ||||
| Working Capital | 34.66 M | ||||
About Forte Biosciences Performance
Evaluating Forte Biosciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Forte Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Forte Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.81) | (0.85) | |
| Return On Capital Employed | (0.92) | (0.87) | |
| Return On Assets | (0.81) | (0.85) | |
| Return On Equity | (0.89) | (0.94) |
Things to note about Forte Biosciences performance evaluation
Checking the ongoing alerts about Forte Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Forte Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Forte Biosciences is way too risky over 90 days horizon | |
| Forte Biosciences appears to be risky and price may revert if volatility continues | |
| Forte Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Forte Biosciences currently holds about 38.55 M in cash with (28.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.89. | |
| Forte Biosciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: Forte Biosciences Shares Are Soaring Today Whats Going On |
- Analyzing Forte Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Forte Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Forte Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Forte Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Forte Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Forte Biosciences' stock. These opinions can provide insight into Forte Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.